Mechanistically, GABPA inhibits P4HA2 expression, thereby reducing collagen cross-linking, whereas GABPA downregulation promotes ECM remodeling, increases tumor stiffness, and results in the acquisition of invasive phenotypes via the mechanotransduction pathway. This evidence concerns the gene P4HA2 and neoplasm.